Cancer, Lung cancer |
|
 |
|
Drugs to treat lung cancer Products: Drugs to treat lung cancer
Glutoxim
NOV-002 in the USA, tradename of Glutoxim in Russia. In clinical trials conducted to date, NOV-002 administered in combination with standard chemotherapeutic regimens has resulted in increased efficacy survival, tumor response) and improved tolerance of standard chemotherapy (e.g. enhanced hematological recovery, immune stimulation).
Tarceva
Approved by FDA in 2005 for use in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer
Approve by FDA in 2004 for treatment of locally advanced or metastatic Non Small-Cell Lung Cancer (NSCLC) after failure of at least one prior chemotherapy regimen.
tarceva lung cancer, tarceva cancer, tarceva 150, erlotinib pancreatic cancer, erlotinib tarceva.
Taxotere
TaxotereŽ (docetaxel) Injection Concentrate Indications:
Breast Cancer
TAXOTEREŽ is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy
TAXOTEREŽ in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer
Non-Small Cell Lung Cancer
TAXOTEREŽ, as a single agent, is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy
TAXOTEREŽ in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic NSCLC who have not previously received chemotherapy for this condition.
Prostate Cancer
TAXOTEREŽ in combination with prednisone is indicated for the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.
Gastric Cancer
TAXOTEREŽ in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease.
Head and Neck Cancer
TAXOTEREŽ in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Vepesid
Vepesid (etoposide) is indicated for use in the treatment of:
1. Small cell carcinoma of the lung.
2. Acute monocytic and myelomonocytic leukaemia.
3. Hodgkin's disease.
4. Non-Hodgkin's lymphoma.
vepesid side effects, vepesid capsules, vepesid injection, vepesid 50, etoposide, etoposide mechanism of action.
|
|
Cancer, Lung cancer
|
|
My Basket